|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2002-10-25
|
|
pubmed:abstractText |
Pimecrolimus cream (Elidel, SDZ ASM 981), a non-steroid inhibitor of inflammatory cytokines, is effective in the treatment of atopic dermatitis (AD). We assessed whether early treatment of AD signs/symptoms reduces the need for topical corticosteroids.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1018-8665
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2002 S. Karger AG, Basel
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
205
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
271-7
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12399676-Administration, Cutaneous,
pubmed-meshheading:12399676-Adolescent,
pubmed-meshheading:12399676-Adult,
pubmed-meshheading:12399676-Aged,
pubmed-meshheading:12399676-Dermatitis, Atopic,
pubmed-meshheading:12399676-Dermatologic Agents,
pubmed-meshheading:12399676-Disease-Free Survival,
pubmed-meshheading:12399676-Double-Blind Method,
pubmed-meshheading:12399676-Female,
pubmed-meshheading:12399676-Humans,
pubmed-meshheading:12399676-Male,
pubmed-meshheading:12399676-Middle Aged,
pubmed-meshheading:12399676-Ointments,
pubmed-meshheading:12399676-Severity of Illness Index,
pubmed-meshheading:12399676-Tacrolimus,
pubmed-meshheading:12399676-Treatment Outcome
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Pimecrolimus cream in the long-term management of atopic dermatitis in adults: a six-month study.
|
|
pubmed:affiliation |
Hautklinik, Universitätsklinikum der TU, Dresden, Deutschland. meurer@rcs.urz.tu-dresden.de
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
